Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 18-23

  Okubo, Yoshiaki ^a   Shimada, Akira ^a   Kanazawa, Yasuhiko ^a   Shigihara, Toshikatsu ^a   Oikawa, Yoichi ^a   Imai, Takatoshi ^a   Miyazaki, Junichi ^b   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adjuvant; MIN6; NOD mouse; Regeneration; Type 1 diabetes

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL COUNT; CELL HYPERPLASIA; CELL KILLING; CELL LINE; CELL REGENERATION; CELL STRAIN MIN6N 9A; CELL THERAPY; CONTROLLED STUDY; DISEASE MODEL; EFFECTOR CELL; FEMALE; HEMATOPOIETIC CELL; HISTOLOGY; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; REMISSION;

ANIMALS; DIABETES MELLITUS, TYPE 1; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HYPERPLASIA; INSULIN; INTERFERON TYPE II; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED ICR; MICE, INBRED NOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 37549022620     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.08.020     Document Type: Article

References (13)

1. Ryu S., Kodama S., Ryu K., Schoenfeld D.A., and Faustman D.L. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J. Clin. Invest. 108 (2001) 63-72
2. Kodama S., Kuhtreiber W., Fujimuara S., Dale E.A., and Faustman D.L. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302 (2003) 1223-1227
3. Chong A.S., Shen J., Tao J., Yin D., Kuznetsov A., Hara M., et al. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived β cell regeneration. Science 311 (2006) 1774-1775
4. Nishio J., Gaglia J.L., Turvey S.E., Campbell C., Benoist C., and Mathis D. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 311 (2006) 1775-1778
5. Suri A., Calderon B., Esparza T.J., Frederick K., Bittner P., and Unanue E.R. Immunological reversal of autoimmune diabetes without hematopoietic replacement of β cells. Science 311 (2006) 1778-1780
6. Kasuga A., Maruyama T., Takei I., Shimada A., Kasatani T., Watanabe K., et al. The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines. Diabetolgia 36 (1993) 1252-1257
7. Miyazaki J., Araki K., Yamato E., Ikegami H., Asano T., Shibasaki Y., et al. Establishment of pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127 (1990) 126-132
8. Kodama S., Davis M., and Faustman D.L. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis. Cell Mol. Life Sci. 62 (2005) 1850-1862
9. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
10. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., and Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9 (2003) 1202-1208
11. Tang Q., Adams J.Y., Tooley A.J., Bi M., Fife B.T., Serra P., et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7 (2006) 83-92
12. Couzin J. Diabetes studies conflict on power of spleen cells. Science 311 (2006) 1694
13. Faustman D.L., Tran S.D., Kodama S., Lodde B.M., Szalayova I., Key S., et al. Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice. Science 314 (2006) 1243